Skip to main content

LCD L34324: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography

LCD L34324, Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography, is the Local Coverage Determination that Noridian Healthcare Solutions, LLC applies to claims from 13 states plus 3 territories (AK, AS, AZ, CA, GU, HI, ID, MP and others), effective 2025-10-16 and first in force 2015-10-01. The policy text runs 1,162 words, and its billing and coding article A57183 lists 594 ICD-10-CM codes that support medical necessity for 14 procedure codes. No other contractor publishes a policy with this title.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Noridian Healthcare Solutions, LLC
States and territories
16
AK AS AZ CA CNMI GU HI ID MT ND NV OR SD UT WA WY
Revision effective
2025-10-16
Original effective
2015-10-01
Policy text
1,162 words
Covered ICD-10 codes (articles)
594

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34324
ContractContractorTypeStates
03201Noridian Healthcare Solutions, LLCA and B MACMT
03301Noridian Healthcare Solutions, LLCA and B MACND
03401Noridian Healthcare Solutions, LLCA and B MACSD
03501Noridian Healthcare Solutions, LLCA and B MACUT
03601Noridian Healthcare Solutions, LLCA and B MACWY
03102Noridian Healthcare Solutions, LLCA and B MACAZ
03202Noridian Healthcare Solutions, LLCA and B MACMT
03302Noridian Healthcare Solutions, LLCA and B MACND
03502Noridian Healthcare Solutions, LLCA and B MACUT
03602Noridian Healthcare Solutions, LLCA and B MACWY
03402Noridian Healthcare Solutions, LLCA and B MACSD
03101Noridian Healthcare Solutions, LLCA and B MACAZ
02201Noridian Healthcare Solutions, LLCA and B MACID
02101Noridian Healthcare Solutions, LLCA and B MACAK
02301Noridian Healthcare Solutions, LLCA and B MACOR
02401Noridian Healthcare Solutions, LLCA and B MACWA
02202Noridian Healthcare Solutions, LLCA and B MACID
02102Noridian Healthcare Solutions, LLCA and B MACAK
02402Noridian Healthcare Solutions, LLCA and B MACWA
02302Noridian Healthcare Solutions, LLCA and B MACOR
01111Noridian Healthcare Solutions, LLCA and B MACCA
01211Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01311Noridian Healthcare Solutions, LLCA and B MACNV
01911Noridian Healthcare Solutions, LLCA and B MACAS CA CNMI GU HI NV
01112Noridian Healthcare Solutions, LLCA and B MACCA
01182Noridian Healthcare Solutions, LLCA and B MACCA
01212Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01312Noridian Healthcare Solutions, LLCA and B MACNV

Billing and coding article A57183: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57183 (Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57183: Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography (Billing and Coding, effective 2026-10-01)

Covered ICD-10-CM codes
594
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
14
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57183
ICD-10-CMDescription (FY2027)
A18.84Tuberculosis of heart
E10.10Type 1 diabetes mellitus with ketoacidosis without coma
E10.11Type 1 diabetes mellitus with ketoacidosis with coma
E10.21Type 1 diabetes mellitus with diabetic nephropathy
E10.22Type 1 diabetes mellitus with diabetic chronic kidney disease
E10.29Type 1 diabetes mellitus with other diabetic kidney complication
E10.311Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema
E10.319Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema
E10.3211Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye
E10.3212Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye
E10.3213Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
E10.3219Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye
E10.3291Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
E10.3292Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye
E10.3293Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral
E10.3299Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye
E10.3311Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye
E10.3312Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
E10.3313Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral
E10.3319Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye
E10.3391Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye
E10.3392Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye
E10.3393Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral
E10.3399Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye

Procedure codes: 93015, 93016, 93017, 93018, 93320, 93321, 93325, 93350, 93351, 93352, J0153 (Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)), J1245 (Injection, dipyridamole, per 10 mg), J1250 (Injection, dobutamine hydrochloride, per 250 mg), J3490 (Unclassified drugs).

Coverage indications, limitations and medical necessity

CARDIOVASCULAR STRESS TESTING

A cardiovascular stress test is a diagnostic test designed to evaluate a patient for the presence or the severity of coronary artery disease (CAD), exercise-induced arrhythmias or hemodynamic changes, and/or cardiac functional capacity.

The cardiovascular stress test is performed using continuous electrocardiographic monitoring (ECG), monitoring blood pressure and pulse, and measuring changes in cardiac electrical activity during and after the use of a cardiac stressor (exercise or a drug). Exercise-induced changes in the ST-T segment of the ECG are measured and correlated with each level of cardiac stress achieved during the test.

The patient’s heart is stressed by walking, then by running on a treadmill, or by riding a stationary bicycle, or by climbing up and down steps. When the patient is unable to perform exercise (e.g., is unable to walk, run, or bicycle), cardiac stress may be induced with intravenous (IV) medication. An interpretation and written report includes a review of the actual ECG recordings of the raw unprocessed data, for comparison with any averages the exercise test monitor generates.

STRESS ECHOCARDIOGRAPHY

Stress echocardiography adds a sound wave image of the heart (echocardiogram) to the electrical monitoring. A two-dimensional (2-D) echocardiographic image of the heart is made and recorded during rest. A second 2-D image is made 30 seconds to two minutes after exercise. The two images are compared and the changes noted.

Stress echocardiography can measure exercise-induced changes in regional ventricular wall motion, ventricular wall thickness, ventricular end-systolic volume, and ventricular ejection fraction (LVEF). Such changes offer mechanical evidence of exercise-induced cardiac muscle dysfunction, presumably due to reduced blood flow through one or more diseased coronary arteries.

RADIONUCLIDE IMAGING

Selected patients may have electrocardiographic findings that make interpretation difficult or other factors that make it reasonable and necessary to perform cardiovascular stress testing in association with radionuclide imaging. As indicated in the ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging, “In general, use of cardiac radionuclide imaging (RNI) for diagnosis and risk assessment in intermediate- and high-risk patients with coronary artery disease (CAD) was viewed favorably, while testing in low-risk patients, routine repeat testing, and general screening in certain clinical scenarios were viewed less favorably. Additionally, use for perioperative testing was found to be inappropriate except for high selected groups of patients.”

INDICATIONS OF COVERAGE

Cardiovascular Stress Testing:

A cardiovascular stress test is covered for a patient who:

• Has signs or symptoms consistent with CAD:

• Angina pectoris or anginal equivalent symptoms,

• Cardiac rhythm disturbances,

• Unexplained syncope,

• Heart failure, or

• Significant atherosclerotic vascular disease elsewhere in the body (e.g., carotid obstructive disease, peripheral vascular disease involving the lower extremities, or abdominal aortic aneurysm.

• Has a metabolic disorder known to cause CAD:

• Diabetes mellitus,

• Syndrome X, or

• Atherogenic hypercholesterolemia.

• Has an abnormal ECG consistent with CAD.

• Needs an evaluation for progression of CAD with the potential for a change in treatment:

• Following coronary artery bypass graft (CABG) surgery;

• Following a myocardial infarction (MI);

• Following a percutaneous transluminal coronary angioplasty (PTCA), atherectomy, intracoronary thrombolysis, or other coronary revascularization procedure;

• Following medical treatment to reverse or stabilize CAD; or

• For a history of a coronary artery ischemic event without symptoms (e.g., a prior “silent MI”).

• Needs an evaluation as part of a preoperative assessment when intermediate- or high-risk for CAD is present and surgery is likely to induce significant cardiac stress.

• Needs an evaluation when information from the clinical assessment does not adequately assess functional capacity when such information is needed to manage the patient (e.g., for a patient with angina to assess the level of exercise tolerance for treatment planning).

Stress Echocardiogram

A stress echocardiogram is reasonable and necessary in addition to an electrical stress test in the following instances:

• An electrical stress test alone is not useful or effective, and a stress echocardiogram is needed. Such circumstances may include:

• An abnormal resting ECG due to digitalis, left ventricular hypertrophy, bundle branch block, preexcitation syndrome (Wolff-Parkinson-White), electronically paced ventricular rhythm, or greater than 1 mm of resting ST depression;

• A prior equivocal stress ECG; or

• A history of posterior wall MI.

• The patient has significant valvular heart disease, and measuring the physiologic changes with exercise is necessary to determine the need for a valve intervention,

• When needed to determine the significance or the extent of myocardial ischemia (or scar), or to assess myocardial viability (e.g., risk stratification following acute myocardial infarction),

• When information from the clinical assessment and an electrical stress test does not adequately assess functional capacity, and such information is needed to manage the patient (e.g., for a patient with angina and left bundle branch block to assess the level of exercise tolerance for treatment planning),

• When needed to aid in diagnosis of hypertrophic or dilated cardiomyopathy,

• When needed to differentiate ischemic from non-ischemic cardiomyopathy,

• As part of a preoperative evaluation of a patient who is at intermediate or high risk for CAD when the surgery is likely to induce significant cardiac stress.

Radionuclide Imaging

The medical necessity for use of RNI must be independently documented in the medical record. Documentation reference to the ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging, or a similar standard will help to assure sufficient evidence that the testing is reasonable and necessary

LIMITATIONS OF COVERAGE:

Cardiovascular stress testing would not be considered “Reasonable and Necessary” when:

• The incremental information obtained from a repeat test or from the addition of an echocardiogram to an electrical stress test is of no clinical relevance.

• The results of the test have no potential to affect the treatment of the patient, such as when the patient has a severe comorbidity that is likely to limit life expectancy and/or likely to limit his/her candidacy for revascularization.

• Secondary conditions will potentially decrease both the sensitivity and specificity of testing (e.g., immediate postoperative period, anemia, or infection).

• A stress test is performed too frequently (See the Utilization Guidelines section).

Medicare will not cover cardiovascular stress testing:

• For Screening CAD (e.g., in a patient without signs or symptoms of CAD), such as for the presence of risk factors— smoking, obesity, family history of CAD, but no personal history of vascular disease or related metabolic disorder.

• When used solely to motivate changes in lifestyle.

• To qualify a patient for a noncovered service, such as fitness training, a weight loss program, or an occupational fitness evaluation.

• For a preoperative assessment prior to either a noncovered surgery or a covered surgery if the reasonable and necessary criteria for the testing is not documented.

A stress echocardiogram is not reasonable and necessary if performed simultaneously with the following additional tests:

• Radionuclide ventriculography;

• A myocardial perfusion imaging stress test with or without pharmacological stress.

Typically, a patient will not require both a stress echocardiogram and a stress nuclear test for the same clinical problem.

Summary of evidence (opening)

N/A

The contractor cites 12 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2025-10-16
Last reviewed by the contractor
2021-03-02
MCD version
38
Derived from
L33515

The contractor lists one National Coverage Determination as related: NCD 20.10 Cardiac Rehabilitation Programs - RETIRED. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Other related documents: A55553 (Response to Comments), A55554 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Noridian Healthcare Solutions, LLC hub lists every other active policy from the same contractor.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34324 cover?

A cardiovascular stress test is a diagnostic test designed to evaluate a patient for the presence or the severity of coronary artery disease (CAD), exercise-induced arrhythmias or hemodynamic changes, and/or cardiac functional capacity. The full 1,162-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34324 apply to?

Noridian Healthcare Solutions, LLC applies it to Medicare claims in 13 states plus 3 territories: AK, AS, AZ, CA, GU, HI, ID, MP, MT, ND, NV, OR, SD, UT, WA, WY. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34324?

The companion billing and coding article A57183 lists 594 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34324?

A denial under LCD L34324 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57183's 594 covered diagnosis codes, then file a redetermination with Noridian Healthcare Solutions, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.